Document is current
Any future updates will be listed below
-
Authors
Tran-Duy, An https://orcid.org/0000-0003-0224-2858
Asbury, Sarah
Spelman, Tim
Paterson, David L.
Buising, Kirsty L.
McDougall, Catherine
Solomon, Michael
Crawford, Ross
Adie, Sam
Molnar, Robert
Mulford, Johnthan
Harris-Brown, Tiffany
Roney, Janine
de Steiger, Richard
Peel, Trisha N.
,
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (APP1120331)
University of Melbourne
- License Information
-
More Information
Article History
Received: 14 September 2025
Accepted: 19 February 2026
First Online: 13 March 2026
Declarations
:
: Conceptualisation : AT-D, TNP. Data Collection & Curation : All authors. Methodology and Data Analysis : AT-D. Interpretation : All authors. Writing – Original Draft : AT-D. Writing – Review : All authors. Critical Revision : AT-D. Supervision : AT-D, RdS, TNP. Funding Acquisition: TNP, the ASAP Trial Group.
: David Paterson served as a member of the Scientific Advisory Board for the AMR Action Fund and as a consultant for Aurobac, BioVersys, CARB-X, Entasis, and Spero. He has received research funding from Merck, Pfizer Inc., and Shionogi, as well as honoraria from bioMérieux, Merck, and Pfizer Inc. for lectures on antimicrobial resistance. Trisha Peel is a section editor for Native Vertebral Osteomyelitis and Linezolid for UpToDate. All other authors have no conflicts of interest relevant to the contents of this article.
: De-identified data are available upon request to researchers with an approved proposal, contingent on signing a data access agreement.
